Vascular, stromal and tumour surface antigens are read in tissue and in flow cytometry, and both readings turn on the same two things: whether the epitope survives the processing, and whether the antigen is restricted enough for the claim being made. Several of these are also therapeutic targets, so catalogues carry staining clones, blocking clones and biosimilar forms that are not interchangeable.
A lyve1 antibody and a periostin antibody on lymphatics and stroma
The lymphatic vessel receptor is one of the few markers that separates lymphatic from blood endothelium reliably, and that specificity is the whole reason to use it, so the control is a section containing both vessel types rather than a positive cell line. The matrix protein is secreted and accumulates in remodelling tissue, which means the honest readouts are a section, conditioned medium or a matrix fraction, not a whole cell lysate where the unassembled pool is all that shows.
A fap antibody and a glypican 3 antibody on activated stroma and tumour
Fibroblast activation protein is expressed on the stroma of many tumours and barely on normal tissue, which is what makes it an imaging and therapeutic target and what makes clone specificity against the related dipeptidyl peptidase essential. The proteoglycan is a hepatocellular carcinoma marker whose diagnostic value rests on a documented staining pattern with an internal control, and it is membrane anchored with a glycan-rich extracellular part, so retrieval conditions change the result more than the antibody's affinity does.
A claudin 18.2 antibody and a muc1 antibody on epithelial surfaces
The tight junction protein splice variant is a gastric target where the antibody has to discriminate between isoforms that differ in a short extracellular loop, which is exactly the kind of specificity a datasheet has to evidence rather than assert. The mucin is heavily glycosylated and its epitopes are famously glycoform dependent, so two clones against the same protein can report different populations in the same section. Where either result supports a decision, cite the clone and show the control tissue.
A timp2 antibody and a tgfbi antibody on secreted regulators
Both are secreted, so the sample decides the answer: conditioned medium concentrated if needed, or a matrix fraction, with a lysate read only as the intracellular pool. The metalloproteinase inhibitor forms complexes with its proteases, and a clone may see the free protein, the complex, or both, which changes what a band means. Serum in the medium carries both proteins, which is why a serum-free window before collection is part of the method rather than an inconvenience.
Staining clone, blocking clone and biosimilar
For a target that is also a drug, catalogues list reagents with three different purposes: a staining clone specified by pattern in tissue or by flow performance, a function-blocking clone specified by the concentration that inhibits a stated assay, and a research grade biosimilar of a clinical molecule specified by sequence. Using a staining clone in a blocking experiment produces a negative result that means nothing, and using a biosimilar as a detection reagent produces background from its own Fc.
Processing decides more than affinity here
Extracellular epitopes on glycosylated surface proteins are the least stable things in a section: over-fixation masks them, aggressive retrieval destroys morphology, and enzymatic dissociation for flow cytometry cleaves several of them outright. The practical approach is to fix the processing first on control tissue, then choose among clones validated under that processing, rather than choosing a clone and hoping the protocol suits it. Where a marker carries a diagnostic claim, the pattern in a known positive and a known negative is the evidence, every run.
Questions people ask about endoglin antibody
Why does the same mucin clone stain different cells than another?
Because its epitopes are glycoform dependent. Two clones against one protein can report different populations, so the clone belongs in the method.
Can a secreted protein be measured in a cell lysate?
Only the intracellular pool. Conditioned medium or a matrix fraction is the honest sample, collected in a serum-free window.
Is a biosimilar antibody a detection reagent?
No. It is specified by sequence for functional work, and its own Fc gives background in staining. Use a validated staining clone instead.